H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: RemeGen(688331) the Revenue is 5.85 B (--%), Beat estimate;the EBIT is 4.355 B (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
5.85B--
3.34B--
+2.51B--%
EBITExceed expectations
4.36B--
1.75B--
+2.60B--%
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf